Drug intelligence / Profile preview

Duopi Yin

Development stage: Unknown
Lead developer: Qinngnianqiushi Project of China Association of Chinese Medicine
Administration: Oral

Overview

Duopi Yin is a Traditional Chinese Medicine (TCM) formula, typically prepared as granules, that is being investigated for the treatment of chronic refractory urticaria. It is composed of a combination of various herbal ingredients, primarily barks, which are believed to exert their therapeutic effects through the principles of TCM.

Other names: 多皮饮

Beyond the preview

Go deeper on Duopi Yin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Duopi Yin.

Explore the full profile